Pharma Trend
  • Pharma Trend
  • Pharma Award
    • Golden Tablet
    • Most innovative Product
    • Honorary Award
  • Pharma Ranking
  • Impressions
  • Sponsors & Partners
  • News
    • Gastroenterologists
    • Industry
    • Pain Therapists
    • Urologists

Lilly ranks 9th in the Pharma Trend Ranking 2022

October 7, 2022 by Editorial staff
  • 1 Eli Lilly, entrepreneur and philanthropist
  • 2 Multiple awards for Lilly for innovation and sustainability

In the cross-specialist ranking “Best Pharmaceutical Companies Germany” 2022, Lilly comes in 9th place in the category “research-based, world-leading pharmaceutical companies by turnover”. The first places in the category went to Janssen-Cilag, Novartis and Bayer Vital/Jenapharm. Lilly is a pioneer in metabolic research and has, among other things, important antidiabetics on the market and in the pipeline.

Eli Lilly, entrepreneur and philanthropist

Eli Lilly and Company was founded in 1876 by the pharmacist, officer and philanthropist Dr. Eli Lilly in Indianapolis/USA. Today, the company is one of the world’s leading pharmaceutical groups. With more than 35,000 employees – around 15,000 of them in the USA – and production and research facilities in seven countries each, the company had a turnover of USD 28.32 billion in 2021 (+18.14% compared to the previous year). More than half of the turnover was generated in the USA, USD 4.78 billion in Europe, USD 5.7 billion in other countries; USD 1.66 billion was also generated in China.

About 8,100 people (23% of the workforce) work in research and development (R&D) at Lilly. R&D spending increased significantly to USD 7.02 billion in 2021, or a quarter of sales, which is a relatively high proportion.

The company’s history is closely linked to metabolic research. In 1923, Lilly launched Iletin®, the first insulin preparation for diabetes mellitus, which had been fatal until then. Other milestones in the company’s history include penicillin production (1943), a Salk polio vaccine (1955), the first commercial genetically engineered insulin (Humulin®, 1982) and the first analogue insulin (Humalog®, 1996). In addition to diabetology, Lilly made a name for itself in oncology, dermatology, cardiology, rheumatology, osteology and psychiatry/neurology.

Top-selling medicines include Trulicity® (dulaglutide/diabetes), Humalog® (insulin lispro), Alimta® (pemetrexed/cancer), Forsteo® (teriparatide®/osteoporosis) and Taltz® (ixekizumab/psoriasis).

The veterinary medicines division Elanco Animal Health – acquired by Novartis in 2014 – was completely spun off from the group by 2019.

Thanks to its successful product development in the fields of diabetes, immunology and cancer therapy, Lilly has become the secret star among the Big Pharma companies, according to Handelsblatt (18.5.2022). A milestone could be the introduction of Mounjaro® (tirzepatide) (US approval 5/2022, EMA recommendation 7/2022). With “Twincretin”, a new antidiabetic drug class is emerging that leads to strong weight loss.

Corporate management, marketing and sales, IT and administration of Lilly Deutschland GmbH and Lilly Pharma Holding GmbH are located in Bad Homburg. Lilly Pharma Produktion GmbH & Co. is based in Norderfriedrichskoog in Schleswig-Holstein. The 885 employees in Germany generated sales of 832 million euros in 2021.

Lilly Germany claims to be the first company in the pharmaceutical industry with a certified Common Good Balance Sheet (GWB), which holistically describes an organisation’s contribution to the common good.

The philanthropic legacy of the founder has been carried on by the Eli Lilly and Company Foundation since 1968.

Multiple awards for Lilly for innovation and sustainability

Since the start of the Pharma Trend benchmark study in 2000, Lilly has already received the “Golden Tablet” award for innovation and sustainability twice (2017, 2018). Lilly first received the award “The Most Innovative Product” in 2000 for Zyprexa®, followed by Cialis® (2003, 2004), Forsteo® (2005), Yentreve® (2005 – 2007) and Byetta® (2007). In 2017, Lilly was voted the best pharmaceutical company in the category “research-based, world-leading pharmaceutical companies by sales”.

Awards für Innovation und Nachhaltigkeit seit 2000:

  • The Golden Tablet (2017,2018)
  • Zyprexa® (2000 – 2002)
  • Cialis® (2003, 2004)
  • Forsteo® (2005)
  • Yentreve® (2005 – 2007)
  • Byetta® (2007)
About the award ceremony

The awards were announced on 13 September 2022 at the Deutsches Museum in Munich. The keynote speech was given by the patron of the event, the Bavarian Minister of Health Klaus Holetschek, Bavarian State Ministry of Health and Care. The festive awards ceremony was hosted by TV presenter Tamara Sedmak (Sat 1, n-tv, N24).

Pharma Trend - The market research on innovation and sustainability

The basis for the ranking and the awards is the Pharma Trend benchmark study, which has been conducted annually in the Rx category among physicians in Germany since 2000 and since 2018 also in the OTC and Orphan Drugs categories, and since 2019 also in the Specialty Care category on behalf of the PharmaBarometer magazine (https://pharmabarometer.de/pharmabarometer/). In 2021, the study was expanded to include the categories “Diagnostics” and “Digital Health Applications”. With the expansion of Pharma Trend, companies in pharmaceuticals and medical technology are assessed on innovation and sustainability via their most important stakeholders – doctors, pharmacists and patients. This year, Pharma Trend was conducted online with 700 physicians, including allergists, general practitioners, dermatologists, gynaecologists, oncologists/haematologists, paediatricians and urologists, as well as 100 pharmacists and 600 patients.

Further information on Pharma Trend and the report volumes at https://pharma-trend.com/en/

Related posts:

  1. Gedeon Richter receives “The Most Innovative Product” award from gynaecologists for Ryeqo® and is ranked second in the Pharma Trend Ranking 2022
  2. ALK-Abelló ranks 3rd in Pharma Trend Ranking 2022
  3. BioNTech wins the “Golden Tablet” of general practitioners, receives the award “The Most Innovative Product” twice for Comirnaty® and places 6th in the Pharma Trend Ranking 2022
  4. Procter & Gamble ranks 5th in Pharma Trend Ranking 2022
Posted in: Allgemein Tagged: Ranking

Patronage

Melanie Huml, Minister of Bavarian State Ministry of Health and Care

Pharma Trend Image and Innovation Award

The survey of innovation and sustainability in pharmaceutical companies.

  • Deutsch (Deutschland) language flag Deutsch
  • English (United States) language flag English

In the News

  • With New Vertical, Innova Solutions Focuses on Advancing Innovation in Healthcare & Life Sciences February 1, 2023
  • Curative Insurance Company’s Financial Strength Affirmed with A- (Excellent) Rating from AM Best February 1, 2023
  • HEXO Announces Election of Directors February 1, 2023
  • agilon health Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results January 31, 2023
  • Cross Country Healthcare to Hold Fourth Quarter and Full Year 2022 Earnings Conference Call on Wednesday, February 22, 2023 January 31, 2023

Partners




Bio M ist Partner der Goldenen Tablette



Media Partnerships





Esanum ist Medienpartner der Goldenen Tablette







Sponsors & Partners:


ashfield
lucky7even is sponsor of Pharma Trend
Harris Interactive is partner of Pharma Trend
PharmaBarometer
Dorothea Küsters Life Science Communications
APOVID
Esanum
MCC Logo
JJ Sustainability is sponsor of Pharma Trend
Healthcare Marketing Logo weiß
Bio-M
Gesdat Logo
tiny web is sponsor of Pharma Trend

Copyright © 2021 Eurecon Verlag GmbH

Imprint   |   Privacy Statement